Chesnara plc, together with its subsidiaries, engages in the life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. More Details
Flawless balance sheet, good value and pays a dividend.
Share Price & News
How has Chesnara's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CSN is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: CSN's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: CSN underperformed the UK Insurance industry which returned 22.6% over the past year.
Return vs Market: CSN underperformed the UK Market which returned 22.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Chesnara's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StWe Think Shareholders May Want To Consider A Review Of Chesnara plc's (LON:CSN) CEO Compensation Package
3 months ago | Simply Wall StIs Chesnara plc's (LON:CSN) Stock On A Downtrend As A Result Of Its Poor Financials?
3 months ago | Simply Wall StDon't Buy Chesnara plc (LON:CSN) For Its Next Dividend Without Doing These Checks
Is Chesnara undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CSN (£2.73) is trading below our estimate of fair value (£6.32)
Significantly Below Fair Value: CSN is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CSN is poor value based on its PE Ratio (19.3x) compared to the UK Insurance industry average (16.4x).
PE vs Market: CSN is good value based on its PE Ratio (19.3x) compared to the UK market (23.6x).
Price to Earnings Growth Ratio
PEG Ratio: CSN's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: CSN is good value based on its PB Ratio (0.8x) compared to the GB Insurance industry average (1.3x).
How is Chesnara forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSN's earnings are forecast to decline over the next 3 years (-1.7% per year).
Earnings vs Market: CSN's earnings are forecast to decline over the next 3 years (-1.7% per year).
High Growth Earnings: CSN's earnings are forecast to decline over the next 3 years.
Revenue vs Market: Insufficient data to determine if CSN's revenue is forecast to grow faster than the UK market.
High Growth Revenue: Insufficient data to determine if CSN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CSN's Return on Equity is forecast to be low in 3 years time (7.2%).
How has Chesnara performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CSN has a large one-off loss of £28.2M impacting its December 31 2020 financial results.
Growing Profit Margin: CSN's current net profit margins (3.3%) are lower than last year (5.5%).
Past Earnings Growth Analysis
Earnings Trend: CSN's earnings have declined by 0.7% per year over the past 5 years.
Accelerating Growth: CSN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CSN had negative earnings growth (-73.1%) over the past year, making it difficult to compare to the Insurance industry average (-20.7%).
Return on Equity
High ROE: CSN's Return on Equity (4.4%) is considered low.
How is Chesnara's financial position?
Financial Position Analysis
Short Term Liabilities: CSN's short term assets (£8.1B) exceed its short term liabilities (£576.0M).
Long Term Liabilities: CSN's short term assets (£8.1B) exceed its long term liabilities (£8.0B).
Debt to Equity History and Analysis
Debt Level: CSN's debt to equity ratio (14.1%) is considered satisfactory.
Reducing Debt: CSN's debt to equity ratio has reduced from 27.1% to 14.1% over the past 5 years.
Debt Coverage: CSN's debt is well covered by operating cash flow (76.5%).
Interest Coverage: CSN's interest payments on its debt are well covered by EBIT (24x coverage).
What is Chesnara current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CSN's dividend (8.04%) is higher than the bottom 25% of dividend payers in the UK market (1.31%).
High Dividend: CSN's dividend (8.04%) is in the top 25% of dividend payers in the UK market (4%)
Stability and Growth of Payments
Stable Dividend: CSN's dividends per share have been stable in the past 10 years.
Growing Dividend: CSN's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (155.4%), CSN's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CSN's dividends in 3 years are not forecast to be well covered by earnings (103.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
John Deane (63 yo)
Mr. John Vincent Deane, FIA, has been the Group Chief Executive Officer of Chesnara plc since January 1, 2015. Mr. Deane served as the Chief Executive of Intermediary Business at The Royal London Mutual In...
CEO Compensation Analysis
Compensation vs Market: John's total compensation ($USD1.09M) is above average for companies of similar size in the UK market ($USD728.48K).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
Experienced Management: CSN's management team is seasoned and experienced (6.5 years average tenure).
Experienced Board: CSN's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Chesnara plc's company bio, employee growth, exchange listings and data sources
- Name: Chesnara plc
- Ticker: CSN
- Exchange: LSE
- Founded: 2003
- Industry: Life and Health Insurance
- Sector: Insurance
- Market Cap: UK£409.897m
- Shares outstanding: 150.15m
- Website: https://www.chesnara.co.uk
Number of Employees
- Chesnara plc
- Building 4
- 2nd Floor
- PR1 8UY
- United Kingdom
Chesnara plc, together with its subsidiaries, engages in the life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through CA, Movestic, Waard Grou...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/31 04:21|
|End of Day Share Price||2021/07/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.